cbdMD, Inc. reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported sales was USD 8.87 million compared to USD 11.35 million a year ago. Revenue was USD 8.59 million compared to USD 10.56 million a year ago. Net loss was USD 31.63 million compared to net income of USD 1.54 million a year ago. Basic loss per share from continuing operations was USD 24.75 compared to basic earnings per share from continuing operations of USD 0.9 a year ago. Diluted loss per share from continuing operations was USD 24.75 compared to diluted earnings per share from continuing operations of USD 0.9 a year ago.
For the nine months, sales was USD 28.67 million compared to USD 36.94 million a year ago. Revenue was USD 27.54 million compared to USD 34.69 million a year ago. Net loss was USD 55.45 million compared to USD 20.37 million a year ago. Basic loss per share from continuing operations was USD 44.55 compared to USD 18 a year ago. Diluted loss per share from continuing operations was USD 44.55 compared to USD 18 a year ago.